Q16539 (MK14_HUMAN) Homo sapiens (Human)
Mitogen-activated protein kinase 14 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
246 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of double-phosphorylated p38alpha with ATF2(83-102) |
Heteromer P15336; | 100 | 1×3FF; | |||
| Crystal structure of human p38alpha complexed with a MAPK docking peptide |
Heteromer P52564; | 99.7 | ||||
| Structure of dead kinase MAPK14 with bound the KIM domain of MKK6 |
Heteromer P52564; | 99.7 | ||||
| Structure of MAPK14 with bound the KIM domain of the Toxoplasma protein GRA24 |
Heteromer B6KJB6; | 100.0 | ||||
| Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer |
Heteromer P49137; | 100.0 | ||||
| Phosphorylated p38 and MAPKAPK2 complex with inhibitor |
Heteromer P49137; | 100.0 | 1×39G; | |||
| Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer |
Heteromer P49137; | 100.0 | ||||
| Structure of the MAPK p38alpha in complex with its activating MAP2K MKK6 |
Heteromer P52564; | 99.71 | 2×AP2; 4×MG; | |||
| Human P38 MAP kinase in complex with RL48 | homo-2-mer | 100.0 | 2×R48; 4×BOG; 1×MES; | |||
| P38 ALPHA map kinase complexed with a benzothiazole based inhibitor | homo-2-mer | 100.0 | 4×P41; | |||
| P38ALPHA MAP KINASE BOUND TO CMPD 29 | monomer | 100.0 | 1×AAV; 1×CL; | |||
| Human p38 MAP Kinase in Complex with 2-amino-phenylamino- dibenzosuberone | monomer | 100.0 | 1×2A8; | |||
| Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridazine Inh… | monomer | 100 | 1×P66; | |||
| Joint NMR and X-ray refinement reveals the structure of a novel dibenzo[a,d]cycloheptenone inhibito… | monomer | 100 | ||||
| Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | monomer | 100 | 1×LI2; 1×GOL; | |||
| Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | monomer | 100 | 1×WBT; | |||
| Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | monomer | 100 | 1×LI3; 3×GOL; 1×DMS; | |||
| Human P38 MAP kinase in complex with RL45 | monomer | 99.11 | 1×1BU; 1×BOG; | |||
| Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inh… | monomer | 100 | 1×P37; | |||
| Crystal Structure of Human p38alpha complexed with a pyridinone compound | monomer | 100.0 | 1×P36; 2×I46; | |||
| p38 Kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×L10; | |||
| p38 Kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×L12; | |||
| p38 Kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×3IP; | |||
| p38alpha bound to pyrazolourea | monomer | 100.0 | 1×1PP; | |||
| fragment based p38 inhibitors | monomer | 100 | 1×L09; | |||
| Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | monomer | 100 | 1×LI4; | |||
| Structure of inactive MAPK14 with ordered Activation Loop | monomer | 100 | 1×SO4; | |||
| p38 Kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×L11; | |||
| Structure of dead kinase MAPK14 | monomer | 99.72 | ||||
| P38 Complexed with a quinazoline inhibitor | monomer | 100 | 1×P40; | |||
| Structural basis for kinase selectivity of three clinical p38alpha inhibitors | monomer | 100.0 | 1×SB2; 2×BOG; 3×EDO; | |||
| mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A | monomer | 99.7 | 1×BOG; | |||
| The W197A mutant of p38a MAP kinase | monomer | 99.7 | ||||
| Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor | monomer | 100 | 1×SO4; 1×6NP; | |||
| Crystal structure of P38 with triazolopyridine | monomer | 100 | 1×TZY; | |||
| Human p38 MAP kinase in complex with NP-F4 and RL87 | monomer | 100.0 | 1×IRG; 1×0OM; | |||
| Human p38 MAP kinase in complex with NP-F1 and RL87 | monomer | 100.0 | 1×IRG; 1×0OK; | |||
| Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenone | monomer | 100.0 | 2×BOG; 1×N3F; | |||
| Human p38 MAP kinase in complex with NP-F5 and RL87 | monomer | 100.0 | 1×IRG; 1×0ON; | |||
| Human p38 MAP kinase in complex with NP-F6 and RL87 | monomer | 100.0 | 1×IRG; 1×0OO; | |||
| fragment based p38 inhibitors | monomer | 100 | 1×2CH; | |||
| Human p38 MAP kinase in complex with NP-F7 and RL87 | monomer | 100.0 | 1×IRG; 2×0OP; | |||
| Triazolopyridine Inhibitors of p38 | monomer | 100 | 1×YIX; | |||
| P38ALPHA MAP KINASE BOUND TO CMPD 22 | monomer | 100.0 | 1×QC0; | |||
| THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 | monomer | 99.43 | 1×SB5; | |||
| Human p38 MAP kinase in complex with NP-F2 and RL87 | monomer | 100.0 | 1×NAR; 1×IRG; | |||
| THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 | monomer | 100 | 1×SB4; | |||
| THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 | monomer | 100 | 1×SB6; | |||
| THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 | monomer | 100 | 1×SB2; | |||
| Human p38 MAP kinase in complex with NP-F3 and RL87 | monomer | 100.0 | 1×IRG; 1×0OL; | |||
| Human p38 MAP kinase in complex with RL163 | monomer | 100.0 | 2×6RG; | |||
| Human p38 MAP Kinase in Complex with RL99 | monomer | 99.1 | 1×BOG; 1×Z86; | |||
| Crystal structure of p38 alpha in complex with compound 75 (MCP33) | monomer | 99.41 | 1×LB5; | |||
| Crystal structure of p38 alpha in complex with compound 81 (MCP42) | monomer | 99.41 | 4×EDO; 1×LB8; | |||
| p38a bound with SR348 | monomer | 99.69 | 1×OE8; | |||
| P38 kinase crystal structure in complex with R1487 | monomer | 99.71 | 1×3FN; | |||
| Human p38 MAP kinase in complex with RL87 | monomer | 100.0 | 2×IRG; | |||
| Crystal structure of p38 alpha in complex with compound 77 (MCP41) | monomer | 99.41 | 1×LBB; | |||
| p38alpha in complex with pyrazolobenzothiazine inhibitor COXP4M12 | monomer | 100.0 | 1×BOG; 1×9Y8; | |||
| Human P38 alpha Mitogen-Activated Kinase In Complex With SB239063 | monomer | 100.0 | 1×GG5; 1×SB0; 1×EDO; 1×BME; | |||
| Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitor | monomer | 100.0 | 1×G6A; 4×GOL; | |||
| Human p38 MAP Kinase in Complex with RL49 | monomer | 99.1 | 1×R49; 1×BOG; 1×GOL; | |||
| Covalent Inhibitor 4a bound to the Lipid Pocket of p38alpha Mutant S251C | monomer | 99.69 | 1×9O2; | |||
| Human p38 MAP Kinase in Complex with RL182 | monomer | 99.11 | 1×BOG; 1×DG7; | |||
| Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitor | monomer | 100.0 | 1×19B; 3×GOL; | |||
| Human p38 MAP Kinase in Complex with Dasatinib | monomer | 100.0 | 1×1N1; 1×BOG; | |||
| Human p38 MAP Kinase in Complex with a Benzylpiperazin-Pyrrol | monomer | 99.11 | 1×PP0; 3×BOG; | |||
| Human p38 MAP kinase in complex with NP-F11 and RL87 | monomer | 100.0 | 1×IRG; 1×0OQ; | |||
| P38 ALPHA MUTANT C162S IN COMPLEX WITH CMPD2 [N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan… | monomer | 99.71 | 1×8EN; | |||
| Structure of human p38aMAPK-arylpyridazinylpyridine fragment complex used in inhibitor discovery | monomer | 100.0 | 1×VVT; 1×GG5; 1×BME; | |||
| Crystal structure of p38alpha Y323Q active mutant | monomer | 99.69 | 1×BOG; | |||
| Crystal structure of P38alpha Y323R active mutant | monomer | 99.7 | 2×BOG; | |||
| Human P38 MAP Kinase in Complex with RL62 | monomer | 98.82 | 1×SS6; 2×BOG; | |||
| Human p38 MAP Kinase in Complex with RL116 | monomer | 99.1 | 1×BOG; 1×Z84; | |||
| Human p38 MAP Kinase in Complex with CP-547632 | monomer | 99.1 | 1×BOG; 1×BFF; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9g | monomer | 100.0 | 1×8OH; | |||
| The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor | monomer | 100 | 1×094; | |||
| Human p38 MAP Kinase in Complex with an Indole Derivative | monomer | 99.11 | 2×BOG; 1×DF3; | |||
| Human p38 MAP Kinase in Complex with RL98 | monomer | 99.1 | 1×Z87; 1×BOG; | |||
| The structure of p38 alpha in complex with a triazol inhibitor | monomer | 100.0 | 1×FTZ; | |||
| Human p38 MAP Kinase in Complex with RL113 | monomer | 99.09 | 1×Z85; 1×BOG; | |||
| p38(alpha) MAP kinase with the activation loop of ERK2 | monomer | 100 | 1×BOG; 1×EPE; | |||
| P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-8-methyl-2-((S)-1-methyl-2-te… | monomer | 100.0 | 1×FMK; | |||
| The structure of p38 alpha in complex with a triazol inhibitor | monomer | 100.0 | 1×P0F; | |||
| Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11J | monomer | 100.0 | 2×287; | |||
| The structure of p38alpha in complex with a dihydroquinazolinone | monomer | 99.71 | 1×B45; | |||
| p38 kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×CQ0; | |||
| Human p38 MAP Kinase in Complex with RL40 | monomer | 100.0 | 1×BOG; 1×G97; 1×MES; | |||
| Crystal structure of P38 in complex with 4-anilino quinoline inhibitor | monomer | 100.0 | 1×ACT; 1×GK1; 1×GOL; | |||
| P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-isopropylamino-8-methyl-8h-… | monomer | 100.0 | 1×FLY; | |||
| P38 kinase crystal structure in complex with RO5634 | monomer | 100.0 | 1×FL4; | |||
| mitogen activated protein kinase p38alpha (D176A) activating mutant | monomer | 100.0 | 1×BOG; | |||
| Human P38 alpha MAPK In Complex With a Novel and Selective Small Molecule Inhibitor | monomer | 100.0 | 2×GG5; 1×LM3; 2×BME; 1×PEG; | |||
| mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B | monomer | 99.69 | 1×BOG; | |||
| Crystal structure of P38 alpha in complex with DP802 | monomer | 100 | 1×EDD; | |||
| X-ray structure of p38alpha bound to TAK-715 | monomer | 100.0 | 1×T75; 1×BOG; | |||
| Crystal structure of P38 kinase in complex with a pyrrole-2-carboxamide inhibitor | monomer | 100.0 | 1×1GK; 3×GOL; | |||
| Crystal structure of P38 kinase in complex with a biphenyl amide inhibitor | monomer | 100 | 1×GK6; 1×GOL; | |||
| P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-8-methyl-2-((R)-1-methyl-2-te… | monomer | 100.0 | 1×533; | |||
| P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-((s)-2-methanesulfonyl-1-me… | monomer | 100.0 | 1×891; | |||
| P38 kinase crystal structure in complex with RO2530 | monomer | 100.0 | 1×530; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9l | monomer | 100.0 | 1×8ON; | |||
| Human p38 MAP Kinase in Complex with RL39 | monomer | 100.0 | 2×BOG; 1×R39; | |||
| The structure of p38alpha in complex with an arylpyridazinone | monomer | 99.71 | 2×222; 2×GOL; | |||
| THE STRUCTURE OF P38ALPHA C162S MUTANT | monomer | 99.71 | 2×MG; | |||
| P38 kinase crystal structure in complex with 4-(5-Methyl-3-phenyl-isoxazol-4-yl)-pyrimidin-2-ylamine | monomer | 100.0 | 1×FMJ; | |||
| triazolopyridine inhibitors of p38 kinase. | monomer | 100.0 | 1×YIS; 1×I46; | |||
| triazolopyridine inhibitors of p38 kinase | monomer | 100.0 | 1×YIW; 1×I46; | |||
| P38 kinase crystal structure in complex with RO6226 | monomer | 100.0 | 1×XI2; | |||
| P38 kinase crystal structure in complex with RO7125 | monomer | 100.0 | 1×FKN; | |||
| P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7V | monomer | 100.0 | 1×39P; | |||
| P38 kinase crystal structure in complex with RO9552 | monomer | 100.0 | 1×FKL; | |||
| Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 … | monomer | 99.41 | 1×T75; | |||
| Structure of Inactive Human p38 MAP Kinase in Complex with a Thiazole-Urea | monomer | 99.1 | 1×HIZ; 1×BOG; | |||
| X-ray structure of p38alpha bound to SCIO-469 | monomer | 100.0 | 1×469; 1×BOG; | |||
| Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate | monomer | 100.0 | 1×GG5; 2×3GF; 1×CL; | |||
| P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor | monomer | 100.0 | 1×3NW; | |||
| Crystal structure of P38 in complex with biphenyl amide inhibitor | monomer | 100 | 1×GK3; 1×GOL; | |||
| Crystal Structure of P38 Kinase in Complex with a biphenyl amide inhibitor | monomer | 100 | 1×SO4; 1×GK5; 1×GOL; | |||
| The structure of p38 alpha in complex with a dihydroquinolinone | monomer | 99.71 | 1×358; 1×GOL; | |||
| Crystal structure of p38 in complex with a biphenylamide inhibitor | monomer | 100.0 | 1×G11; 1×SO4; 6×GOL; | |||
| P38 kinase crystal structure in complex with pamapimod | monomer | 100.0 | 1×FLW; | |||
| P38 kinase crystal structure in complex with RO6224 | monomer | 100.0 | 1×FML; | |||
| Human p38 alpha MAPK in complex with a pyridazine based inhibitor | monomer | 100.0 | 1×GG5; 2×MWL; 1×ZN; 1×CL; 1×BME; 1×GOL; 1×ACT; 1×PEG; | |||
| p38alpha MAP kinase bound to pyrazoloamine | monomer | 100.0 | 1×PQA; | |||
| Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Triazolopyridazinone i… | monomer | 100 | 1×09J; | |||
| p38 kinase crystal structure in complex with small molecule inhibitor | monomer | 100 | 1×I2O; | |||
| P38ALPHA MAP KINASE BOUND TO CMPD 8 | monomer | 100.0 | 1×AQZ; | |||
| Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative | monomer | 100.0 | 1×FS8; 1×BOG; | |||
| P38 kinase crystal structure in complex with RO4499 | monomer | 99.7 | 1×FI4; | |||
| p38alpha MAP kinase bound to MPAQ | monomer | 100.0 | 1×AQZ; | |||
| p38 kinase Crystal structure in complex with small molecule inhibitor | monomer | 100.0 | 1×I39; | |||
| P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor | monomer | 100.0 | 1×OCG; | |||
| P38 kinase crystal structure in complex WITH 8-Methyl-6-phenoxy-2-(tetrahydro-pyran-4-ylamino)-8H-p… | monomer | 100.0 | 1×FLZ; | |||
| Human P38 MAP Kinase in Complex with SB203580 | monomer | 98.81 | 1×SB2; 2×BOG; | |||
| Human p38 MAP Kinase in Complex with Scios-469 | monomer | 99.1 | 1×BOG; 1×469; | |||
| Human p38 MAP Kinase in Complex with RL24 | monomer | 100.0 | 1×R24; 1×BOG; 1×MES; | |||
| P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor | monomer | 100.0 | 1×NK0; | |||
| P38 kinase crystal structure in complex with 6-(2,4-Difluoro-phenoxy)-2-((R)-2-methanesulfonyl-1-me… | monomer | 100.0 | 1×FLS; | |||
| Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compo… | monomer | 100.0 | 3×BOG; 1×GE5; | |||
| Crystal structure of p38 kinase bound to pyrimido-pyridazinone inhibitor | monomer | 100.0 | 1×CL; 1×52P; | |||
| Human p38 MAP Kinase in Complex with an Imidazo-pyridine | monomer | 99.1 | 3×BOG; 1×IPK; | |||
| P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor | monomer | 100.0 | 1×N4D; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9c | monomer | 100.0 | 1×8OW; | |||
| Human p38alpha MAP Kinase in Complex with Dibenzosuberone Compound 2 | monomer | 100.0 | 1×78L; | |||
| THE COMPLEX STRUCTURE OF THE MAP KINASE P38/Compound 14b | monomer | 100.0 | 1×5JZ; | |||
| Crystal structure of P38 in complex with biphenyl amide inhibitor | monomer | 100.0 | 1×GK4; 2×GOL; | |||
| p38alpha in complex with pyrazolobenzothiazine inhibitor COXH11 | monomer | 100.0 | 1×9Y5; | |||
| Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with ETHYL 6-((5-(CYCLOPR… | monomer | 100.0 | 1×1RA; | |||
| P38 in complex with T-3220137 | monomer | 99.39 | 1×MKP; | |||
| Human p38 MAP Kinase in Complex with RL51 | monomer | 100.0 | 1×L51; 2×BOG; 1×MES; | |||
| Crystal structure of p38alpha Y323T active mutant | monomer | 99.71 | 1×BOG; | |||
| Human p38 MAP Kinase in Complex with Skepinone-L | monomer | 100.0 | 2×BOG; 1×3FF; | |||
| p38 kinase Crystal structure in complex with small molecule inhibitor | monomer | 100.0 | 1×MIH; | |||
| P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7K | monomer | 100.0 | 1×38P; | |||
| P38 complex with a phthalazine inhibitor | monomer | 100.0 | 1×A17; | |||
| mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant | monomer | 99.69 | 3×BOG; | |||
| Human p38 MAP Kinase in Complex with RL166 | monomer | 99.1 | 2×BOG; 1×Z83; | |||
| Human p38 MAP kinase in complex with NP-F10 and RL87 | monomer | 100.0 | 3×0SJ; 1×IRG; | |||
| Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 … | monomer | 99.41 | 1×AQY; | |||
| Crystal structure of Y323F inactive mutant of p38alpha MAP kinase | monomer | 99.7 | 2×BOG; | |||
| Crystal structure of human p38 alpha complexed with a pyrimidinone compound | monomer | 100.0 | 1×29A; 1×29B; | |||
| P38 Alpha Map Kinase inhibitor based on heterobicyclic scaffolds | monomer | 100.0 | 1×LGF; | |||
| Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibito… | monomer | 100.0 | 3×BOG; 1×GXH; | |||
| Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (comp… | monomer | 100.0 | 3×BOG; 1×GEW; | |||
| p38alpha bound to novel DGF-out compound PF-00215955 | monomer | 100.0 | 1×JZJ; 2×I46; | |||
| P38 alpha complex with AR117045 | monomer | 100.0 | 1×I46; 1×HYK; | |||
| MAPK14 with bound inhibitor SR-318 | monomer | 99.4 | 1×NA; 1×LBE; 1×GOL; | |||
| P38 Kinase Crystal Structure in complex with RO3201195 | monomer | 100.0 | 1×PQB; | |||
| Structure of human p38alpha with N-[4-methyl-3-(6-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}pyridine… | monomer | 100 | 1×KQ7; 5×ACT; | |||
| A Novel Lipid Binding Site in the p38 alpha MAP Kinase | monomer | 100.0 | 2×BOG; | |||
| P38ALPHA MAP KINASE BOUND TO CMPD 2 | monomer | 100.0 | 1×AA0; | |||
| Dibenzooxepinone inhibitor 12b in complex with p38 MAPK | monomer | 100.0 | 1×FJI; 2×BOG; | |||
| Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based … | monomer | 99.4 | 1×J8S; | |||
| P38 alpha complex with AR117046 | monomer | 100.0 | 1×I46; 1×HYW; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9m | monomer | 100.0 | 1×8OK; | |||
| Human p38alpha MAPK in complex with imidazolyl pyridine inhibitor 11b | monomer | 100.0 | 3×BOG; 1×1VI; | |||
| Structure of MAP kinase p38 in complex with a 1-o-tolyl-1,2,3-triazole-4-carboxamide | monomer | 98.81 | 1×337; | |||
| Crystal Structure of Human p38alpha complexed with PH-797804 | monomer | 100.0 | 1×I45; 1×I46; 1×PO2; | |||
| Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N… | monomer | 100.0 | 1×1M8; | |||
| P38alpha bound to novel DFG-out compound PF-00416121 | monomer | 100.0 | 1×F4C; 1×I46; | |||
| P38 kinase crystal structure in complex with RO3668 | monomer | 99.71 | 1×FKO; | |||
| Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics … | monomer | 99.7 | 1×BOG; | |||
| Crystal Structure of Human p38alpha Complexed With a Triazolopyrimidine compound | monomer | 100.0 | 1×L9G; | |||
| Structure of p38a MAP kinase without BOG | monomer | 100.0 | ||||
| P38 kinase crystal structure in complex with RO6257 | monomer | 100.0 | 1×RO6; | |||
| Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Div… | monomer | 100.0 | 1×BOG; 1×B11; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9h | monomer | 100.0 | 2×8OT; | |||
| Human P38 MAP Kinase in Complex with Inhibitor 1a | monomer | 100.0 | 1×BOG; 1×BI5; | |||
| HUMAN P38 MAP KINASE INHIBITOR COMPLEX | monomer | 100.0 | 3×D13; | |||
| Conformational plasticity of p38 MAP kinase DFG-motif mutants in response to inhibitor binding | monomer | 99.7 | 1×BMU; 1×BOG; | |||
| Covalent Inhibitor 4b bound to the Lipid Pocket of p38alpha Mutant S252C | monomer | 99.7 | 1×9O5; | |||
| Human P38alpha MAPK in Complex with a Novel and Selective Small Molecule Inhibitor | monomer | 100.0 | 2×GG5; 1×LM4; 1×ZN; 1×ACT; 1×BME; 1×GOL; | |||
| p38a-PIA23 complex | monomer | 100.0 | 1×0O9; | |||
| Crystal structure of P38 alpha in complex with DP437 | monomer | 100 | 1×437; | |||
| Human P38 MAP kinase in complex with Sorafenib | monomer | 99.09 | 1×BAX; 1×BOG; | |||
| Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics … | monomer | 100.0 | 1×BOG; | |||
| P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR | monomer | 100.0 | 1×FPH; | |||
| Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | monomer | 99.7 | 1×SB2; 1×BOG; | |||
| Crystal structure of human p38alpha MAP kinase | monomer | 100.0 | 2×GG5; | |||
| Human p38 MAP kinase in complex with a Dibenzoxepinone | monomer | 100.0 | 2×BOG; 1×F46; | |||
| Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | monomer | 99.7 | 1×BMU; 1×BOG; | |||
| P38 kinase crystal structure in complex with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-p… | monomer | 100.0 | 1×FSS; | |||
| P38 in complex with Sorafenib | monomer | 100.0 | 1×BAX; | |||
| Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a… | monomer | 99.7 | 1×BOG; | |||
| Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a… | monomer | 99.7 | 1×BOG; | |||
| Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 2-(2-CHLOROPHENYL)-N… | monomer | 100.0 | 1×1R9; | |||
| Crystal structure of phosphorylated P38 alpha in complex with DP802 | monomer | 100.0 | 1×EDD; | |||
| THE STRUCTURE OF P38ALPHA | monomer | 100.0 | 1×SO4; | |||
| Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics a… | monomer | 99.7 | 1×BOG; | |||
| Dibenzosuberone inhibitor 8e in complex with p38 MAPK | monomer | 100.0 | 1×HB9; 2×BOG; | |||
| P38ALPHA MAP KINASE BOUND TO CMPD 33 | monomer | 100.0 | 1×NQB; | |||
| p38a-perifosine Complex | monomer | 100.0 | 1×0O8; | |||
| Crystal structure of P38 alpha in complex with DP1376 | monomer | 100 | 1×EDB; | |||
| Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor | monomer | 100 | 1×SO4; 1×DQO; | |||
| Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11B | monomer | 100.0 | 1×279; | |||
| Human p38 MAP Kinase in Complex with RL38 | monomer | 100.0 | 1×1AU; 1×BOG; | |||
| Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberone | monomer | 100.0 | 1×048; 2×BOG; | |||
| Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9j | monomer | 100.0 | 1×BW1; 1×B96; | |||
| Crystal structure of a N-Phenyl-N'-Naphthylurea analog in complex with p38 MAP kinase | monomer | 99.39 | 1×B10; | |||
| Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor binding | monomer | 99.7 | 1×BMU; 1×BOG; | |||
| P38 alpha map kinase complexed with BMS-640994 | monomer | 100.0 | 1×304; | |||
| Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based … | monomer | 99.7 | 1×J9G; | |||
| The structure of p38 alpha in complex with a pyridinylimidazole inhibitor | monomer | 100 | 1×SO4; 1×084; | |||
| P38 in complex with Imatinib | monomer | 100.0 | 1×STI; 1×BOG; | |||
| p38 MAP Kinase in Complex with Inhibitor 1 | monomer | 100.0 | 1×BMU; | |||
| p38-alpha complexed with Compound 10 | monomer | 99.7 | 1×3NE; | |||
| Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | monomer | 99.7 | 1×BMU; 1×EDO; | |||
| Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2 | monomer | 100.0 | 1×P39; | |||
| THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6… | monomer | 100 | 1×MSQ; | |||
| The crystal structure of p38a MAP kinase in complex with PIA24 | monomer | 100.0 | 1×0OA; | |||
| Human p38 MAP Kinase in Complex with BIRB 796 | monomer | 100.0 | 1×B96; | |||
| Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor binding | monomer | 99.7 | 1×SB2; | |||
| Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inh… | monomer | 100.0 | 1×LHJ; | |||
| P38a MAP kinase DEF-pocket penta mutant (M194A, L195A, H228A, I229A, Y258A) | monomer | 98.47 | 2×BOG; | |||
| Structure of p38 alpha (Mitogen-activated protein kinase 14) complexed with inhibitor 6 | monomer | 100.0 | 2×A1AD9; | |||
| Crystal Structure of Human p38alpha complexed with SD-0006 | monomer | 100.0 | 1×I47; 1×I46; | |||
| Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | monomer | 100.0 | 1×79Q; 2×BOG; | |||
| Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | monomer | 99.7 | 1×BMU; 1×BOG; 1×EDO; | |||
| Human p38 MAP Kinase in Complex with KM064 | monomer | 100.0 | 1×06F; 2×BOG; | |||
| STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE M… | monomer | 100.0 | ||||
| Crystal Structure of Human p38alpha complexed with a pyrimidopyridazinone compound | monomer | 100.0 | 1×52P; 2×I46; | |||
| Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30 | monomer | 100.0 | 1×P38; | |||
| X-ray structure of p38alpha bound to VX-745 | monomer | 100.0 | 1×52P; 1×BOG; | |||
| p38alpha bound to Ro3201195 | monomer | 99.7 | 1×PQB; | |||
| ERK2 MAP kinase with the activation loop of p38alpha | monomer | 100.0 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1wbs.1.A | monomer | 0.87 | 1×LI2; | 100.00 | ||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3d83.1.A | monomer | 0.86 | 1×GK6; | 96.11 | ||
| Isoform 3 | 1wbs.1.A | monomer | 0.82 | 1×LI2; | 91.19 | ||
| Isoform 4 | 5etc.1.A | monomer | 0.80 | 88.73 | |||
| Isoform 5 | 1ouy.1.A | monomer | 0.85 | 1×094; | 99.61 | ||